Pilleve's aim is to fill in the gap between opioid prescription and addiction, which has affected millions of Americans and resulted in thousands of accidental overdoses. Pilleve decreases the costs of opioid abuse and addiction for insurance companies, providers, loved ones and patients. This ranges from accidental overdoses to long term treatment. We do that by detecting the signs earlier, intervening, and ensuring patients are using their prescription opioids safely. In doing so, pilleve decreases the social and financial burden that cripples patients and their stakeholders.

Washington, DC, USA

Pilleve

500 Global is an early-stage venture fund and seed accelerator with a network of startup programs headquartered in Silicon Valley.

We’re investing in the world’s best companies, and you’ll love working for them.